![]() |
市場調査レポート
商品コード
1297828
消化器内視鏡用ガイドワイヤーの世界市場-2023年~2030年Global GI Endoscopy Guidewire Market - 2023-2030 |
||||||
カスタマイズ可能
適宜更新あり
|
消化器内視鏡用ガイドワイヤーの世界市場-2023年~2030年 |
出版日: 2023年06月15日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
|
消化器内視鏡用ガイドワイヤーの世界市場は、2022年に2億5,750万米ドルに達し、2030年には3億4,990万米ドルまで成長すると予測されています。消化器内視鏡用ガイドワイヤーの世界市場は、予測期間中(2023-2030年)に4.5%のCAGRを示すと予測されています。
ガイドワイヤにはさまざまな長さと直径があり、多くの場合、ステンレス鋼または同等の材料で構成されています。内視鏡の付属チャンネルや作業チャンネルから挿入され、内視鏡医が消化管内の目的部位にガイドワイヤーを進めることができます。
特に大腸がんの検診率の増加は、消化器疾患の早期発見と検診の価値に対する一般市民の意識の高まりの結果です。ガイドワイヤの使用は、大腸内視鏡検査のようなスクリーニング検査で頻繁に必要とされます。このような手術におけるガイドワイヤーの必要性は、検診率が上がるにつれて高まる。
消化器内視鏡検査で異常が見つかった場合、場合によっては治療的措置が必要になることもあります。生検鉗子、ポリープ切除用スネア、狭窄・狭窄用ステントなどの治療器具はすべてガイドワイヤーで誘導することができます。治療的介入の需要とガイドワイヤーの使用は、いずれも検診率の上昇とともに増加します。
消化器内視鏡用ガイドワイヤーの使用増加は、大腸がんなどの消化器疾患を対象とした活動の結果です。これらのプログラムには、検診キャンペーン、公衆衛生キャンペーン、利害関係者とヘルスケアプロバイダーのパートナーシップなどが含まれます。これらのキャンペーンは、認知度を高め、早期発見を促すことで、ガイドワイヤーが必要なものを含め、より多くの人々が消化器内視鏡検査を受けることを奨励しています。内視鏡は、困難な症例の治療中にガイドワイヤーによって誘導され、正確な可視化と確実な診断を可能にします。消化器内視鏡用ガイドワイヤーのニーズは、重点的な取り組みが広まるにつれて増加し、患者の予後改善と消化器疾患の早期治療を促進すると予想されます。
COVID-19の流行は消化器内視鏡用ガイドワイヤー市場に大きな影響を与えました。COVID-19の大流行により、ヘルスケア施設における安全性と感染制御に対する懸念が高まっています。内視鏡施設や病院では、個人用保護具(PPE)の使用の増加、洗浄手順の改善、患者の流れ手順の変更など、より厳格な対策が講じられました。このような措置は、ヘルスケア施設にとって費用と物流上の困難を増大させ、ガイドワイヤーの受け入れと使用に影響を与える可能性があります。
ロシア・ウクライナ紛争が消化器内視鏡用ガイドワイヤー市場に与える影響は複雑かつ多面的です。影響を受けた地域では、暴力によりヘルスケアシステムが大きく混乱しています。病院やその他の医療機関へのアクセスが損なわれ、内視鏡治療やガイドワイヤーなどの関連機器の入手に影響が出ている可能性があります。
The Global GI Endoscopy Guidewire Market reached US$ 257.5 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 349.9 million by 2030. The Global GI Endoscopy Guidewire Market is expected to exhibit a CAGR of 4.5% during the forecast period (2023-2030).
The guidewire comes in a variety of lengths and diameters and is often composed of stainless steel or comparable material. It is inserted through an accessory channel or working channel of the endoscope, allowing the endoscopist to advance it into the targeted area within the GI tract.
Increased screening rates, particularly for colorectal cancer, are the result of growing public awareness of the value of early identification and screening for GI diseases. The use of guidewires is frequently necessary during screening procedures like colonoscopies, which are advised for those over a certain age or who have a certain set of risk factors. The need for guidewires in these operations rises as screening rates do.
Therapeutic measures may be necessary in some instances if GI endoscopic tests reveal abnormalities. Therapeutic tools like biopsy forceps, snares for removing polyps, or stents for narrowing or strictures can all be guided by guidewires. The demand for therapeutic interventions and the use of guidewires both rise with higher screening rates.
The rising use of GI endoscopy guidewires is a result of targeted activities for GI disorders such as colorectal cancer. These programs include screening campaigns, public health campaigns, and stakeholder and healthcare provider partnerships. These campaigns encourage more people to have GI endoscopy procedures, including those requiring guidewires, by increasing awareness and encouraging early detection. Endoscopes are guided by guidewires during therapeutic treatments in difficult cases, enabling precise visualization and reliable diagnosis. The need for GI endoscopic guidewires is anticipated to increase as focused initiatives spread, promoting better patient outcomes and the early treatment of GI disorders.
The COVID-19 pandemic has had a significant impact on the GI Endoscopy Guidewire market. The COVID-19 pandemic increased worries about safety and infection control in healthcare facilities. Stricter measures were put in place by endoscopy facilities and hospitals, including increased use of personal protective equipment (PPE), improved cleaning procedures, and altered patient flow procedures. Although required, these actions increased expenses and logistical difficulties for healthcare facilities, which can have an impact on guidewire acceptance and use.
The impact of the Russia-Ukraine war on the GI endoscopy guidewire market is complex and multifaceted. In the impacted areas, the violence has severely disrupted the healthcare system. The accessibility of hospitals and other medical institutions may have been compromised, affecting the availability of endoscopic treatments and associated equipment, such as guidewires.
The global GI endoscopy guidewire market is segmented based on material, indication, design, end-user, and region.
The colonoscopy segment accounted for the highest market stake accounting for approximately 39.6% of the GI endoscopy guidewire market in 2022. The large intestine (colon) is examined using a colonoscopy, a frequent diagnostic and therapeutic technique, to look for anomalies including polyps, tumors, or inflammation. Although they are not frequently utilized in colonoscopies, guidewires may be used in some circumstances. A guidewire may occasionally be used during a colonoscopy to help the endoscope pass through difficult anatomical variations, strictures, or convoluted sections of the colon. The endoscope can be guided and advanced through the colon with the aid of the guidewire.
Europe is expected to dominate the GI endoscopy guidewire market, accounting for around 26.8% of this market. The market players are offering the products in the region to strengthen their business in the European region. For instance, the Barr 360 express RFA balloon catheter, Barr 360 RFA balloon catheter, and the Barr 360 soft-sizing balloon can all be exchanged with the use of Barr RFA endoscopic guidewires.
The major global players in the market include: Boston Scientific Corporation, CONMED Corporation, COOK MEDICAL Inc, HOBBS MEDICAL INC, Olympus Corporation, Medico's-Hirata Inc, Sumitomo Bakelite Co., Ltd, Diagmed Healthcare, Omnimed Ltd, and Merit medical systems among others.
The global GI endoscopy guidewire market report would provide approximately 68 tables, 69 figures, and 195 pages.
LIST NOT EXHAUSTIVE